Security Risk Assessment Guide for Medication Adherence Device Makers

Medication adherence devices—including connected pill dispensers, smart packaging, and reminder apps—can affect both patient privacy and safe medication use. A security risk assessment helps you understand how a cyberattack, software failure, or unauthorized change could expose information or interfere with reminders, dispensing, or monitoring.

Use this guide to assess risks across the device lifecycle, from design and supplier selection through updates, support, and retirement. FDA cybersecurity guidance for medical devices provides recommendations for device security and premarket documentation; statutory requirements may also apply when a device meets the definition of a “cyber device.”

Define Device Security Boundaries

Start by defining what is included in the device and its connected service. Consider the dispenser or packaging, firmware, mobile app, cloud services, caregiver and clinician portals, APIs, wireless connections, and manufacturing or support systems that can affect the product.

Map how commands and data move between components. Identify where medication schedules, adherence events, patient identifiers, authentication credentials, and device status are created, stored, transmitted, or accessed. Include offline operation, pairing, maintenance, and software-update pathways.

Document trust boundaries: places where data or commands cross between components, users, organizations, or networks. For each boundary, record who can send information, how the recipient verifies it, and what could happen if it is altered, replayed, delayed, or blocked.

Identify Threats and Attack Surfaces

Use threat modeling to examine how an attacker, unauthorized user, or accidental error could affect confidentiality, integrity, availability, or safe operation. Consider the device’s intended users and environments, including patients, caregivers, pharmacies, clinicians, and technicians.

Review attack surfaces such as Bluetooth or Wi-Fi, mobile app interfaces, account recovery, cloud APIs, debug ports, removable media, update mechanisms, and vendor access. Potential threats include stolen credentials, insecure pairing, malicious or compromised updates, exposed databases, denial of service, and tampering with medication schedules or adherence records.

Assess safety consequences as well as data exposure. For example, a blocked reminder, changed schedule, or unavailable dispenser could disrupt a patient’s routine. Consider foreseeable misuse and failures, such as a caregiver using a shared account or a device losing connectivity for an extended period.

Assess Cybersecurity Risks

For each threat, identify the affected asset, vulnerability, possible consequence, likelihood, and existing safeguards. Evaluate impacts on patient safety, device performance, privacy, data integrity, and service availability. A useful assessment connects each cybersecurity scenario to the device function or patient outcome it could affect.

Prioritize risks using a consistent method that reflects both exploitability and potential harm. Record the assumptions behind each rating, the planned mitigation, the person responsible, and any residual risk that remains after controls are applied. Reassess when the design, software, suppliers, operating environment, or threat landscape changes.

FDA guidance recommends lifecycle cybersecurity risk management for medical devices, while the HIPAA Security Rule requires covered entities and business associates to assess risks to electronic protected health information they hold. The assessment method should fit your product and obligations; HIPAA does not automatically apply to every device maker merely because a product handles health-related information.

Protect Medication and Patient Data

Inventory the information your device and services collect, then limit collection and retention to what the product needs. Separate account credentials from adherence records where practical, restrict access by role, and remove or de-identify data when it is no longer needed for a defined purpose.

Protect data in transit and at rest with safeguards appropriate to the risk. Use strong authentication, secure session handling, access controls, audit logging, and encryption where appropriate. Avoid exposing sensitive data in notifications, logs, support tools, or analytics unless it is necessary and properly protected.

The HIPAA Security Rule calls for administrative, physical, and technical safeguards to protect the confidentiality, integrity, and availability of electronic protected health information held by covered entities and business associates. Determine whether your organization has a covered relationship, such as providing services as a business associate, and address applicable obligations through your risk analysis, contracts, and operational controls.

Implement Secure Device Design Controls

Build security into requirements, architecture, implementation, verification, and maintenance. Apply least privilege, secure defaults, input validation, protection against common software flaws, and clear separation between safety-critical functions and less trusted interfaces. Test both normal use and failure conditions, including loss of network access and interrupted updates.

Use secure boot to help ensure that a device starts only with authenticated, authorized software. Protect signing keys, verify updates before installation, and provide a safe recovery path if an update fails. Design updates so they can be delivered and validated throughout the product’s supported life.

Keep a software bill of materials (SBOM) for commercial, open-source, and off-the-shelf components, and establish a process to identify affected products when a component vulnerability is disclosed. For cyber devices subject to section 524B of the FD&C Act, manufacturers have statutory obligations that include providing an SBOM and maintaining processes for vulnerability management and updates.

Manage Third-Party and Supply Chain Risks

Identify suppliers and service providers whose products or access could affect device security, patient data, or availability. This may include component manufacturers, software libraries, cloud providers, app developers, contract manufacturers, and technical support vendors.

Assess supplier security practices before use and throughout the relationship. Set expectations for vulnerability reporting, patch timelines, secure development, access restrictions, incident notification, and end-of-support communication. Ensure contracts and service arrangements address data handling and security responsibilities where applicable.

Track component versions and supplier changes so you can determine which devices, applications, or services may be affected by a newly reported flaw. Include supplier access and update channels in threat modeling, and verify third-party updates before deploying them to devices or services.

Monitor and Respond to Security Incidents

Maintain a vulnerability disclosure program with a clear way for researchers, customers, and partners to report security issues. Triage reports promptly, assess whether a vulnerability affects patient safety or device performance, and coordinate investigation and remediation with relevant suppliers.

Prepare an incident response process that assigns decision-makers, preserves logs and other evidence, evaluates affected devices and data, and defines how to communicate with customers and healthcare partners. Plan how to contain an issue and provide mitigations, patches, or other corrective actions without introducing new safety risks.

Monitor vulnerability notices and reports related to your device and its software components. Test security updates before release, document decisions and residual risks, and reassess the product after incidents or significant changes. FDA postmarket guidance emphasizes ongoing vulnerability monitoring, coordinated disclosure, and timely risk mitigation; HIPAA-regulated organizations also have duties to detect and respond to security incidents involving ePHI.

Across the lifecycle, a strong assessment connects device boundaries and threats to patient and data impacts, then documents controls, responsibilities, and follow-up. Revisit it as the product, its suppliers, and its operating environment evolve.

FAQs

What security risks affect medication adherence devices?

Risks can include unauthorized access to accounts or patient data, altered medication schedules, blocked reminders, disrupted device connectivity, compromised software updates, and attacks on cloud or mobile services. The consequences depend on the device’s functions and how patients, caregivers, and clinicians rely on it.

How should manufacturers assess cybersecurity risks across a device lifecycle?

Map device components, data flows, users, and trust boundaries; use threat modeling to identify attack scenarios; evaluate likelihood and potential effects on safety, privacy, integrity, and availability; and document mitigations and residual risks. Repeat the assessment as the design, software, suppliers, or threat environment changes, and include postmarket monitoring and incident response.

What patient data security requirements apply to medication adherence devices?

Requirements depend on the data and the manufacturer’s role. The HIPAA Security Rule applies to covered entities and business associates handling electronic protected health information, rather than automatically applying to every device manufacturer. Determine whether your organization has a covered relationship and implement appropriate safeguards for data in your care.

How should a manufacturer handle vulnerabilities in a connected medication device?

Provide a clear vulnerability disclosure program, investigate reports promptly, determine the affected products and potential patient impact, and coordinate with relevant suppliers. Develop and test appropriate mitigations or updates, communicate with affected stakeholders, and document decisions and follow-up monitoring. FDA postmarket guidance recommends an ongoing process for identifying, assessing, and addressing cybersecurity vulnerabilities.